Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Acadia, Advantage, Akeso, Annovis, Ceapro, Curium, Engeneic, GSK, Junshi, MC2, Medivir, Onconano, Priovant, Rapt, Regeneron, Roivant, Sanofi, Tharimmune, Vaxxas, Xenon.